EUR 11.5
(0.44%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.75 Billion EUR | 7.29% |
2022 | 3.5 Billion EUR | 12.37% |
2021 | 3.11 Billion EUR | 5.84% |
2020 | 2.94 Billion EUR | 4.08% |
2019 | 2.82 Billion EUR | 8.86% |
2018 | 2.59 Billion EUR | 56.05% |
2017 | 1.66 Billion EUR | 0.54% |
2016 | 1.65 Billion EUR | 1.11% |
2015 | 1.63 Billion EUR | 28.84% |
2014 | 1.27 Billion EUR | -10.31% |
2013 | 1.41 Billion EUR | -2.29% |
2012 | 1.45 Billion EUR | 1.03% |
2011 | 1.43 Billion EUR | 1.58% |
2010 | 1.41 Billion EUR | -7.93% |
2009 | 1.53 Billion EUR | 7.65% |
2008 | 1.42 Billion EUR | 2.02% |
2007 | 1.39 Billion EUR | 29.14% |
2006 | 1.08 Billion EUR | 1.1% |
2005 | 1.07 Billion EUR | 12.85% |
2004 | 949.1 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 Q1 | 278.84 Million EUR | -23.37% |
2023 Q3 | 313.5 Million EUR | -9.08% |
2023 FY | 760.9 Million EUR | -78.28% |
2023 Q4 | 354.2 Million EUR | 12.98% |
2023 Q2 | 344.8 Million EUR | 23.65% |
2022 Q2 | 238.7 Million EUR | 15.09% |
2022 FY | 3.5 Billion EUR | 12.37% |
2022 Q4 | 363.9 Million EUR | 26.29% |
2022 Q3 | 288.15 Million EUR | 20.72% |
2022 Q1 | 207.39 Million EUR | 485.5% |
2021 Q4 | -53.8 Million EUR | -123.77% |
2021 FY | 3.11 Billion EUR | 5.84% |
2021 Q1 | 202.75 Million EUR | 371.06% |
2021 Q2 | -70.5 Million EUR | -134.77% |
2021 Q3 | 226.35 Million EUR | 421.06% |
2020 Q4 | -74.8 Million EUR | -131.61% |
2020 FY | 2.94 Billion EUR | 4.08% |
2020 Q3 | 236.6 Million EUR | 491.07% |
2020 Q2 | -60.5 Million EUR | -132.03% |
2020 Q1 | 188.89 Million EUR | -14.91% |
2019 Q1 | 254.04 Million EUR | 20.8% |
2019 Q2 | 323.9 Million EUR | 27.49% |
2019 Q3 | 170.25 Million EUR | -47.44% |
2019 Q4 | 222 Million EUR | 30.4% |
2019 FY | 2.82 Billion EUR | 8.86% |
2018 FY | 2.59 Billion EUR | 56.05% |
2018 Q4 | 210.3 Million EUR | -26.35% |
2018 Q3 | 285.55 Million EUR | 36.69% |
2018 Q2 | 208.9 Million EUR | 0.0% |
2018 Q1 | 208.9 Million EUR | 12.43% |
2017 Q4 | 185.8 Million EUR | 0.0% |
2017 Q3 | 185.8 Million EUR | -3.81% |
2017 Q1 | 193.15 Million EUR | 8.12% |
2017 Q2 | 193.15 Million EUR | 0.0% |
2017 FY | 1.66 Billion EUR | 0.54% |
2016 Q3 | 178.64 Million EUR | 7.95% |
2016 Q2 | 165.5 Million EUR | 0.0% |
2016 FY | 1.65 Billion EUR | 1.11% |
2016 Q1 | 165.5 Million EUR | -15.43% |
2016 Q4 | 178.64 Million EUR | 0.0% |
2015 Q1 | 159.95 Million EUR | 0.0% |
2015 FY | 1.63 Billion EUR | 28.84% |
2015 Q2 | 159.95 Million EUR | 0.0% |
2015 Q3 | 195.7 Million EUR | 22.35% |
2015 Q4 | 195.7 Million EUR | 0.0% |
2014 FY | 1.27 Billion EUR | -10.31% |
2014 Q2 | 206.8 Million EUR | -51.59% |
2014 Q1 | 427.2 Million EUR | 31.61% |
2013 Q3 | 313.3 Million EUR | 23.83% |
2013 Q1 | 439 Million EUR | 18.87% |
2013 Q2 | 253 Million EUR | -42.37% |
2013 FY | 1.41 Billion EUR | -2.29% |
2013 Q4 | 324.6 Million EUR | 3.61% |
2012 FY | 1.45 Billion EUR | 1.03% |
2012 Q4 | 369.3 Million EUR | 3.5% |
2012 Q3 | 356.8 Million EUR | -1.05% |
2012 Q2 | 360.6 Million EUR | 3.62% |
2012 Q1 | 348 Million EUR | -7.5% |
2011 Q3 | 366.6 Million EUR | 5.92% |
2011 Q4 | 376.2 Million EUR | 2.62% |
2011 Q2 | 346.1 Million EUR | 1.38% |
2011 FY | 1.43 Billion EUR | 1.58% |
2011 Q1 | 341.4 Million EUR | -11.62% |
2010 FY | 1.41 Billion EUR | -7.93% |
2010 Q1 | 344.8 Million EUR | 4.39% |
2010 Q2 | 368.2 Million EUR | 6.79% |
2010 Q3 | 370.6 Million EUR | 0.65% |
2010 Q4 | 386.3 Million EUR | 4.24% |
2009 Q2 | 395.5 Million EUR | 0.0% |
2009 FY | 1.53 Billion EUR | 7.65% |
2009 Q4 | 330.3 Million EUR | -10.95% |
2009 Q3 | 370.9 Million EUR | -6.22% |
2008 FY | 1.42 Billion EUR | 2.02% |
2007 FY | 1.39 Billion EUR | 29.14% |
2006 FY | 1.08 Billion EUR | 1.1% |
2005 FY | 1.07 Billion EUR | 12.85% |
2004 FY | 949.1 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Clariane SE | 1.4 Billion EUR | -167.283% |
LNA Santé SA | 178.1 Million EUR | -2010.18% |